. 2016 Sep 9;11(1):39. doi: 10.1186/s13020-016-0109-6

Table 5.

Fluorogold immunolabeling

Group	1	2	3	4
RGCs (number/mm²) On day 1	1952.16 ± 125.29	929.01 ± 135.00**	1112.65 ± 164.10	1691.36 ± 237.57^††
RGCs (number/mm²) On day 7	1737.23 ± 151.94	887.73 ± 158.18**	941.89 ± 38.91	1389.02 ± 53.20^††

In comparison of the control retina, 1 or 7 days following sham procedure (Sham; Group 1), after retinal ischemia plus 1 or 7 days of reperfusion and pretreatment with vehicle (I/R + Vehicle; Group 2), the number of fluorogold-immunolabeling retinal ganglion cells (RGCs) per field was significantly decreased (** P < 0.01). In contrast, this significant decrease was dose-dependently (with a less effect at 2.8 g/kg/day, I/R + CJDHW2.8; Group 3) and significantly (^†† P < 0.01; at 4.2 g/kg/day, I/R + CJDHW4.2; Group 4) inhibited by pretreatment with CJDHW. The results are the mean ± SD (μm; n = 3)